InMode Ltd. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for INMD, updated each market day.
INMD AI Sentiment
AI sees no strong directional signal for InMode Ltd. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About InMode Ltd. Ordinary Shares
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Exchange
Market Cap
$867,381,287
Cap Tier
Employees
660
Listed Since
Aug. 8, 2019
Website
INMD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INMD Volatility
InMode Ltd. Ordinary Shares has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
